Dianthus Therapeutics (DNTH) Shares Outstanding (Diluted Average) (2020 - 2025)

Dianthus Therapeutics' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $36.5 million for Q3 2025.

• In Q3 2025, Shares Outstanding (Diluted Average) rose 6.54% year-over-year to $36.5 million; the TTM figure through Sep 2025 stood at $36.5 million (up 6.54% YoY), while the FY2024 annual figure was $33.3 million, up 546.44% from the prior year.
• Shares Outstanding (Diluted Average) was $36.5 million for Q3 2025 at Dianthus Therapeutics, up from $35.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $58.8 million in Q2 2022 to a low of $874138.0 in Q3 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $30.3 million across 5 years, with a median of $34.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) tumbled 98.51% in 2023, then surged 3534.12% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $54.9 million in 2021, then slumped by 98.41% to $874234.0 in 2022, then soared by 489.48% to $5.2 million in 2023, then surged by 546.44% to $33.3 million in 2024, then climbed by 9.49% to $36.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $36.5 million (Q3 2025), $35.8 million (Q2 2025), and $35.8 million (Q1 2025), per Business Quant data.